ABAC Therapeutics Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
8
- Latest Deal Type
-
M&A
ABAC Therapeutics General Information
Description
Developer of novel therapeutic alternatives intended to treat patients who are infected with antibiotic-resistant bacterial pathogens. The company's therapeutics are scalable and multiplex, capable of unveiling pathogen-specific antibacterial properties of molecules, while promoting the compounds active against Multiple Drug Resistance (MDR) strains with a new mechanism of action, enabling physicians to use novel compounds against the big four gram-negative bacteria.
Contact Information
Website
www.abactherapeutics.com(Operating Subsidiary)
Corporate Office
- Joan XXIII, 10
- Esplugues de Llobregat
- 08950 Barcelona
- Spain
Corporate Office
- Joan XXIII, 10
- Esplugues de Llobregat
- 08950 Barcelona
- Spain
ABAC Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | Completed | Pre-Clinical Trials | ||||
| 3. Buyout/LBO | 30-Oct-2019 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC (Series A) | 15-Feb-2018 | $19.8M | $20.4M | Completed | Pre-Clinical Trials | |
| 1. Early Stage VC | 13-Nov-2015 | $619K | $619K | Completed | Pre-Clinical Trials |
ABAC Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
ABAC Therapeutics Comparisons
Industry
Financing
Details
ABAC Therapeutics Competitors (17)
One of ABAC Therapeutics’s 17 competitors is Ona Therapeutics, a Venture Capital-Backed company based in Barcelona, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ona Therapeutics | Venture Capital-Backed | Barcelona, Spain | ||||
| Volastra | Venture Capital-Backed | New York, NY | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Melinta Therapeutics | Private Equity-Backed | Parsippany, NJ | ||||
| Spero Therapeutics | Formerly VC-backed | Cambridge, MA |
ABAC Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ABAC Therapeutics Patents
ABAC Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4406952-A1 | New compounds for treating staphylococcus infections | Inactive | 27-Jan-2023 | ||
| WO-2024156895-A1 | New compounds for treating staphylococcus infections | Inactive | 27-Jan-2023 | ||
| EP-4406945-A1 | New compounds for treating streptococcus infections | Inactive | 27-Jan-2023 | ||
| WO-2024156892-A1 | New compounds for treating streptococcus infections | Inactive | 27-Jan-2023 | ||
| EP-3490984-A1 | 2-pyrrolidine phenylhydrazides antibacterial agents | Active | 29-Jul-2016 | C07D207/09 |
ABAC Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ABAC Therapeutics Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Caixa Capital Risc | Corporate Venture Capital | Minority | ||
| Debiopharm Innovation Fund | Corporate Venture Capital | Minority | ||
| Ferrer Internacional | Corporation | Majority | ||
| Pontifax Venture Capital | Venture Capital | Minority | ||
| Quark Venture | Venture Capital | Minority |
ABAC Therapeutics FAQs
-
When was ABAC Therapeutics founded?
ABAC Therapeutics was founded in 2014.
-
Where is ABAC Therapeutics headquartered?
ABAC Therapeutics is headquartered in Barcelona, Spain.
-
What is the size of ABAC Therapeutics?
ABAC Therapeutics has 8 total employees.
-
What industry is ABAC Therapeutics in?
ABAC Therapeutics’s primary industry is Drug Discovery.
-
Is ABAC Therapeutics a private or public company?
ABAC Therapeutics is a Private company.
-
What is ABAC Therapeutics’s current revenue?
The current revenue for ABAC Therapeutics is .
-
How much funding has ABAC Therapeutics raised over time?
ABAC Therapeutics has raised $20.4M.
-
Who are ABAC Therapeutics’s investors?
Caixa Capital Risc, Debiopharm Innovation Fund, Ferrer Internacional, Pontifax Venture Capital, and Quark Venture are 5 of 6 investors who have invested in ABAC Therapeutics.
-
Who are ABAC Therapeutics’s competitors?
Ona Therapeutics, Volastra, Ability Pharma, Melinta Therapeutics, and Spero Therapeutics are some of the 17 competitors of ABAC Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
